Showing results (1-10 of 29) with videos related to
Sort By:
Pageof 3
Sociology of Health & Illness|November 3, 2010
The impact of patient advocacy: the case of innovative breast cancer drug reimbursementRoel Nahuis, Wouter P C BoonJournal of Biopharmaceutical Statistics|March 26, 1999
Design and analysis issues for crossover designs in phase I clinical studiesP C Boon, K C RoesDrug Discovery Today|April 15, 2008
The role of users in innovation in the pharmaceutical industryRuud E H M Smits, Wouter P C BoonMalaysian Journal of Nutrition|May 8, 2014
Malnutrition risk and its association with appetite, functional and psychosocial status among elderly Malays in an agricultural settlementS Suzana, P C Boon, P P Chan, et al.Clinical Pharmacology and Therapeutics|October 22, 2010
Conditional approval and approval under exceptional circumstances as regulatory instruments for stimulating responsible drug innovation in EuropeW P C Boon, E H M Moors, A Meijer, et al.BMC Public Health|April 30, 2022
Expert perspectives on the introduction of Triple Artemisinin-based Combination Therapies (TACTs) in Southeast Asia: a Delphi studyFreek de Haan, Wouter P C Boon, Chanaki Amaratunga, et al.Environmental Innovation and Societal Transitions|February 2, 2022
Market Formation in a Global Health TransitionFreek de Haan, Ellen H M Moors, Arjen M Dondorp, et al.Expert Review of Molecular Diagnostics|June 8, 2022
Impact of the new European Union In Vitro Diagnostics Regulation on the practice of hospital diagnostic laboratoriesAudrey M M Hermans, Marc Maliepaard, Wouter P C Boon, et al.European Radiology|May 28, 2020
Implementation of artificial intelligence (AI) applications in radiology: hindering and facilitating factorsLea Strohm, Charisma Hehakaya, Erik R Ranschaert, et al.NAM Journal|June 29, 2026
Pursuing societal impact in research projects on NAM development: An analysis of routes to impactTessel B Wijne, Wouter P C Boon, Anne S Kienhuis, et al.Pageof 3